Classification Tree Models for the Prediction of Blood—Brain Barrier Passage of Drugs.

Éric Deconinck,Menghui Zhang,Danny Coomans,Yvan Vander Heyden

DOI: https://doi.org/10.1002/chin.200631207

2006-01-01

ChemInform

Abstract:ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

What problem does this paper attempt to address?

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Xiuqing Zhang,Ting Liu,Xiaohui Fan,Ni Ai

DOI: https://doi.org/10.1016/j.jmgm.2017.05.021

2017-01-01

Abstract:In silico modeling of blood-brain barrier (BBB) permeability plays an important role in early discovery of central nervous system (CNS) drugs due to its high-throughput and cost-effectiveness. Natural products (NP) have demonstrated considerable therapeutic efficacy against several CNS diseases. However, BBB permeation property of NP is scarcely evaluated both experimentally and computationally. It is well accepted that significant difference in chemical spaces exists between NP and synthetic drugs, which calls into doubt on suitability of available synthetic chemical based BBB permeability models for the evaluation of NP. Herein poor discriminative performance on BBB permeability of NP are first confirmed using internal constructed and previously published drug-derived computational models, which warrants the need for NP-oriented modeling. Then a quantitative structure property relationship (QSPR) study on a NP dataset was carried out using four different machine learning methods including support vector machine, random forest, Naive Bayes and probabilistic neural network with 67 selected features. The final consensus model was obtained with approximate 90% overall accuracy for the cross-validation study, which is further taken to predict passive BBB permeability of a large dataset consisting of over 10,000 compounds from traditional Chinese medicine (TCM). For 32 selected TCM molecules, their predicted BBB permeability were evaluated by in vitro parallel artificial membrane permeability assay and overall accuracy for in vitro experimental validation is around 81%. Interestingly, our in silico model successfully predicted different BBB permeation potentials of parent molecules and their known in vivo metabolites. Finally, we found that the lipophilicity, the number of hydrogen bonds and molecular polarity were important molecular determinants for BBB permeability of NP. Our results suggest that the consensus model proposed in current work is a reliable tool for prioritizing potential CNS active NP across the BBB, which would accelerate their development and provide more understanding on their mechanisms, especially those with pharmacologically active metabolites. (C) 2017 Elsevier Inc. All rights reserved.
Prediction of blood‐brain barrier permeability using machine learning approaches based on various molecular representation

Li Liang,Zhiwen Liu,Xinyi Yang,Yanmin Zhang,Haichun Liu,Yadong Chen

DOI: https://doi.org/10.1002/minf.202300327

IF: 4.05

2024-06-13

Molecular Informatics

Abstract:The assessment of compound blood‐brain barrier (BBB) permeability poses a significant challenge in the discovery of drugs targeting the central nervous system. Conventional experimental approaches to measure BBB permeability are labor‐intensive, cost‐ineffective, and time‐consuming. In this study, we constructed six machine learning classification models by combining various machine learning algorithms and molecular representations. The model based on ExtraTree algorithm and random partitioning strategy obtains the best prediction result, with AUC value of 0.932±0.004 and balanced accuracy (BA) of 0.837±0.010 for the test set. We employed the SHAP method to identify important features associated with BBB permeability. In addition, matched molecular pair (MMP) analysis and representative substructure derivation method were utilized to uncover the transformation rules and distinctive structural features of BBB permeable compounds. The machine learning models proposed in this work can serve as an effective tool for assessing BBB permeability in the drug discovery for central nervous system disease.

chemistry, medicinal,mathematical & computational biology,computer science, interdisciplinary applications
Brain Embolism‐Induced Injury of Vascular Endothelial Cells and a Novel Vasoprotective Drug

Feng Han,Kohji Fukunaga

DOI: https://doi.org/10.1002/chin.200734269

2007-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
In Silico Prediction of Blood-Brain Barrier Permeability of Chemical Compounds through Molecular Feature Modeling

Tanish Jain,Praveen Kumar Pandian Shanmuganathan

DOI: https://doi.org/10.48550/arXiv.2208.09484

2022-08-18

Quantitative Methods

Abstract:The introduction of computational techniques to analyze chemical data has given rise to the analytical study of biological systems, known as "bioinformatics". One facet of bioinformatics is using machine learning (ML) technology to detect multivariable trends in various cases. Amongst the most pressing cases is predicting blood-brain barrier (BBB) permeability. The development of new drugs to treat central nervous system disorders presents unique challenges due to poor penetration efficacy across the blood-brain barrier. In this research, we aim to mitigate this problem through an ML model that analyzes chemical features. To do so: (i) An overview into the relevant biological systems and processes as well as the use case is given. (ii) Second, an in-depth literature review of existing computational techniques for detecting BBB permeability is undertaken. From there, an aspect unexplored across current techniques is identified and a solution is proposed. (iii) Lastly, a two-part in silico model to quantify likelihood of permeability of drugs with defined features across the BBB through passive diffusion is developed, tested, and reflected on. Testing and validation with the dataset determined the predictive logBB model's mean squared error to be around 0.112 units and the neuroinflammation model's mean squared error to be approximately 0.3 units, outperforming all relevant studies found.
ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors [J. Chem. Inf. Comput. Sci. 43, 2137-2152 (2003)]

Tingjun Hou,Xiaojie Xu

DOI: https://doi.org/10.1021/ci040020a

IF: 6.162

2004-01-01

Journal of Chemical Information and Modeling

Abstract:ADVERTISEMENT RETURN TO ISSUEPREVArticleADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors [J. Chem. Inf. Comput. Sci. 43, 2137−2152 (2003)]T. J. Hou and X. J. XuView Author Information College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China Cite this: J. Chem. Inf. Comput. Sci. 2004, 44, 2, 766–770Publication Date (Web):January 29, 2004Publication History Published online29 January 2004Published inissue 1 March 2004https://doi.org/10.1021/ci040020aCopyright © 2004 American Chemical SocietyRequest reuse permissionsArticle Views232Altmetric-Citations4LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (152 KB) SUBJECTS:Bioinformatics and computational biology,Chemical calculations,Drug discovery,Membranes,Molecular modeling Get e-Alerts
A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors

Fanwang Meng,Yang Xi,Jinfeng Huang,Paul W. Ayers

DOI: https://doi.org/10.1038/s41597-021-01069-5

2021-10-29

Scientific Data

Abstract:Abstract The highly-selective blood-brain barrier (BBB) prevents neurotoxic substances in blood from crossing into the extracellular fluid of the central nervous system (CNS). As such, the BBB has a close relationship with CNS disease development and treatment, so predicting whether a substance crosses the BBB is a key task in lead discovery for CNS drugs. Machine learning (ML) is a promising strategy for predicting the BBB permeability, but existing studies have been limited by small datasets with limited chemical diversity. To mitigate this issue, we present a large benchmark dataset, B3DB, complied from 50 published resources and categorized based on experimental uncertainty. A subset of the molecules in B3DB has numerical log BB values (1058 compounds), while the whole dataset has categorical (BBB+ or BBB−) BBB permeability labels (7807). The dataset is freely available at https://github.com/theochem/B3DB and 10.6084/m9.figshare.15634230.v3 (version 3). We also provide some physicochemical properties of the molecules. By analyzing these properties, we can demonstrate some physiochemical similarities and differences between BBB+ and BBB− compounds.

multidisciplinary sciences
Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds

Frederic O. Dehnbostel,Vaibhav A. Dixit,Robert Preissner,Priyanka Banerjee

DOI: https://doi.org/10.1038/s41598-024-59734-9

IF: 4.6

2024-04-18

Scientific Reports

Abstract:Diseases related to the central nervous system (CNS) are major health concerns and have serious social and economic impacts. Developing new drugs for CNS-related disorders presents a major challenge as it actively involves delivering drugs into the CNS. Therefore, it is imperative to develop in silico methodologies to reliably identify potential lead compounds that can penetrate the blood–brain barrier (BBB) and help to thoroughly understand the role of different physicochemical properties fundamental to the BBB permeation of molecules. In this study, we have analysed the chemical space of the CNS drugs and compared it to the non-CNS-approved drugs. Additionally, we have collected a feature selection dataset from Muehlbacher et al. (J Comput Aided Mol Des 25(12):1095–1106, 2011. 10.1007/s10822-011-9478-1) and an in-house dataset. This information was utilised to design a molecular fingerprint that was used to train machine learning (ML) models. The best-performing models reported in this study achieved accuracies of 0.997 and 0.98, sensitivities of 1.0 and 0.992, specificities of 0.971 and 0.962, MCCs of 0.984 and 0.958, and ROC-AUCs of 0.997 and 0.999 on an imbalanced and a balanced dataset, respectively. They demonstrated overall good accuracies and sensitivities in the blind validation dataset. The reported models can be applied for fast and early screening drug-like molecules with BBB potential. Furthermore, the bbbPythoN package can be used by the research community to both produce the BBB-specific molecular fingerprints and employ the models mentioned earlier for BBB-permeability prediction.

multidisciplinary sciences
The Barrier and Interface Mechanisms of the Brain Barrier, and Brain Drug Delivery.

Shanshan Zhang,Lin Gan,Fengye Cao,Hao Wang,Peng Gong,Congcong Ma,Li Ren,Yubo Lin,Xianming Lin

DOI: https://doi.org/10.1016/j.brainresbull.2022.09.017

IF: 3.715

2022-01-01

Brain Research Bulletin

Abstract:Three different barriers are formed between the cerebrovascular and the brain parenchyma: the blood-brain barrier (BBB), the blood-cerebrospinal fluid barrier (BCSFB), and the cerebrospinal fluid-brain barrier (CBB). The BBB is the main regulator of blood and central nervous system (CNS) material exchange. The semipermeable nature of the BBB limits the passage of larger molecules and hydrophilic small molecules, Food and Drug Administration (FDA)-approved drugs for the CNS have been generally limited to lipid-soluble small molecules. Although the complexity of the BBB affects CNS drug delivery, understanding the composition and function of the BBB can provide a platform for the development of new methods for CNS drug delivery. This review summarizes the classification of the brain barrier, the composition and role of the basic structures of the BBB, and the transport, barrier, and destruction mechanisms of the BBB; discusses the advantages and disadvantages of different drug delivery methods and prospects for future drug delivery strategies.
Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.

Hu Li,Chun Wei Yap,Choong Yong Ung,Ying Xue,Zhi Wei Cao,Yu Zong Chen

DOI: https://doi.org/10.1021/ci050135u

IF: 6.162

2005-01-01

Journal of Chemical Information and Modeling

Abstract:The ability or inability of a drug to penetrate into the brain is a key consideration in drug design. Drugs for treating central nervous system (CNS) disorders need to be able to penetrate the blood-brain barrier (BBB). BBB nonpenetration is desirable for non-CNS-targeting drugs to minimize potential CNS-related side effects. Computational methods have been employed for the prediction of BBB-penetrating (BBB+) and -nonpenetrating (BBB-) agents at impressive accuracies of 75 similar to 92% and 60 similar to 80%, respectively. However, the majority of these studies give a substantially lower BBB- accuracy, and thus overall accuracy, than the BBB+ accuracy. This work examined whether proper selection of molecular descriptors can improve both the BBB- and the overall accuracies of statistical learning methods. The methods tested include logistic regression, linear discriminate analysis, k nearest neighbor, C4.5 decision tree, probabilistic neural network, and support vector machine. Molecular descriptors were selected by using a feature selection method, recursive feature elimination (RFE). Results by using 415 BBB+ and BBB- agents show that RFE substantially improves both the BBB- and the overall accuracy for all of the methods studied. This suggests that statistical learning methods combined with proper feature selection is potentially useful for facilitating a more balanced and improved prediction of BBB+ and BBB- agents.
ChemInform Abstract: ADME Evaluation in Drug Discovery. Part 8. the Prediction of Human Intestinal Absorption by a Support Vector Machine.

Tingjun Hou,Junmei Wang,Youyong Li

DOI: https://doi.org/10.1002/chin.200808228

2008-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
A merged molecular representation deep learning method for blood-brain barrier permeability prediction

Qiang Tang,Fulei Nie,Qi Zhao,Wei Chen

DOI: https://doi.org/10.1093/bib/bbac357

2022-09-20

Abstract:The ability of a compound to permeate across the blood-brain barrier (BBB) is a significant factor for central nervous system drug development. Thus, for speeding up the drug discovery process, it is crucial to perform high-throughput screenings to predict the BBB permeability of the candidate compounds. Although experimental methods are capable of determining BBB permeability, they are still cost-ineffective and time-consuming. To complement the shortcomings of existing methods, we present a deep learning-based multi-model framework model, called Deep-B3, to predict the BBB permeability of candidate compounds. In Deep-B3, the samples are encoded in three kinds of features, namely molecular descriptors and fingerprints, molecular graph and simplified molecular input line entry system (SMILES) text notation. The pre-trained models were built to extract latent features from the molecular graph and SMILES. These features depicted the compounds in terms of tabular data, image and text, respectively. The validation results yielded from the independent dataset demonstrated that the performance of Deep-B3 is superior to that of the state-of-the-art models. Hence, Deep-B3 holds the potential to become a useful tool for drug development. A freely available online web-server for Deep-B3 was established at http://cbcb.cdutcm.edu.cn/deepb3/, and the source code and dataset of Deep-B3 are available at https://github.com/GreatChenLab/Deep-B3.
A prediction model for blood–brain barrier permeation and analysis on its parameter biologically

Yan Chen,Qing-Jun Zhu,Jian Pan,Yi Yang,Xiao-Pei Wu

DOI: https://doi.org/10.1016/j.cmpb.2009.03.006

IF: 6.1

2009-01-01

Computer Methods and Programs in Biomedicine

Abstract:The objective of this paper is to build a reliable model based on the artificial neural network (ANN) for predicting the blood–brain barrier (BBB) permeability and reveal the effects of the molecular descriptor on the BBB permeability. Eight descriptors including high-affinity P-gp substrate probability and plasma protein binding ratio are selected to develop the model. The three layers feedforward neural network (8-5-1) is employed for the prediction of logBB. By analyzing the experimental results, polar surface area (PSA) seems to be the most important factor for BBB permeability. Different from traditional view, the Abraham's hydrogen-bond basicity (HBB) can make a positive contribution to logBB in rational range. The experimental results show that the ANN based model with eight selected descriptors as inputs can achieve good performance for logBB prediction, and the results of sensitivity analysis can be confirmed by the present biological and chemical research.
Predicting blood–brain barrier permeability of molecules with a large language model and machine learning

Eddie T. C. Huang,Jai-Sing Yang,Ken Y. K. Liao,Warren C. W. Tseng,C. K. Lee,Michelle Gill,Colin Compas,Simon See,Fuu-Jen Tsai

DOI: https://doi.org/10.1038/s41598-024-66897-y

IF: 4.6

2024-07-11

Scientific Reports

Abstract:Predicting the blood–brain barrier (BBB) permeability of small-molecule compounds using a novel artificial intelligence platform is necessary for drug discovery. Machine learning and a large language model on artificial intelligence (AI) tools improve the accuracy and shorten the time for new drug development. The primary goal of this research is to develop artificial intelligence (AI) computing models and novel deep learning architectures capable of predicting whether molecules can permeate the human blood–brain barrier (BBB). The in silico (computational) and in vitro (experimental) results were validated by the Natural Products Research Laboratories (NPRL) at China Medical University Hospital (CMUH). The transformer-based MegaMolBART was used as the simplified molecular input line entry system (SMILES) encoder with an XGBoost classifier as an in silico method to check if a molecule could cross through the BBB. We used Morgan or Circular fingerprints to apply the Morgan algorithm to a set of atomic invariants as a baseline encoder also with an XGBoost classifier to compare the results. BBB permeability was assessed in vitro using three-dimensional (3D) human BBB spheroids (human brain microvascular endothelial cells, brain vascular pericytes, and astrocytes). Using multiple BBB databases, the results of the final in silico transformer and XGBoost model achieved an area under the receiver operating characteristic curve of 0.88 on the held-out test dataset. Temozolomide (TMZ) and 21 randomly selected BBB permeable compounds (Pred scores = 1, indicating BBB-permeable) from the NPRL penetrated human BBB spheroid cells. No evidence suggests that ferulic acid or five BBB-impermeable compounds (Pred scores < 1.29423E−05, which designate compounds that pass through the human BBB) can pass through the spheroid cells of the BBB. Our validation of in vitro experiments indicated that the in silico prediction of small-molecule permeation in the BBB model is accurate. Transformer-based models like MegaMolBART, leveraging the SMILES representations of molecules, show great promise for applications in new drug discovery. These models have the potential to accelerate the development of novel targeted treatments for disorders of the central nervous system.

multidisciplinary sciences
DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy

Rajnish Kumar,Anju Sharma,Athanasios Alexiou,Anwar L. Bilgrami,Mohammad Amjad Kamal,Ghulam Md Ashraf

DOI: https://doi.org/10.3389/fnins.2022.858126

IF: 4.3

2022-05-04

Frontiers in Neuroscience

Abstract:The blood-brain barrier (BBB) is a selective and semipermeable boundary that maintains homeostasis inside the central nervous system (CNS). The BBB permeability of compounds is an important consideration during CNS-acting drug development and is difficult to formulate in a succinct manner. Clinical experiments are the most accurate method of measuring BBB permeability. However, they are time taking and labor-intensive. Therefore, numerous efforts have been made to predict the BBB permeability of compounds using computational methods. However, the accuracy of BBB permeability prediction models has always been an issue. To improve the accuracy of the BBB permeability prediction, we applied deep learning and machine learning algorithms to a dataset of 3,605 diverse compounds. Each compound was encoded with 1,917 features containing 1,444 physicochemical (1D and 2D) properties, 166 molecular access system fingerprints (MACCS), and 307 substructure fingerprints. The prediction performance metrics of the developed models were compared and analyzed. The prediction accuracy of the deep neural network (DNN), one-dimensional convolutional neural network, and convolutional neural network by transfer learning was found to be 98.07, 97.44, and 97.61%, respectively. The best performing DNN-based model was selected for the development of the "DeePred-BBB" model, which can predict the BBB permeability of compounds using their simplified molecular input line entry system (SMILES) notations. It could be useful in the screening of compounds based on their BBB permeability at the preliminary stages of drug development. The DeePred-BBB is made available at https://github.com/12rajnish/DeePred-BBB.

neurosciences
1. Applications of Genetic Algorithms to the Prediction of Blood-Brain Partitioning of a Large Set of Drugs

Tingjun Hou,Xiaowei Xu

2002-01-01

Abstract:In this study, the relationships between the brain-blood concentration ratio of 96 structurally diverse compounds with a large number of structurally derived descriptors were investigated. The linear models were based on molecular descriptors that can be calculated for any compound simply from a knowledge of its molecular structure. The linear correlation coefficients of the mod- els were optimized by genetic algorithms (GAs), and the descriptors used in the linear models were automatically selected from 27 structurally derived descriptors. The GA optimizations resulted in a group of linear models with three or four molecular descriptors with good statis- tical significance. The change of descriptor use as the evolution proceeds demonstrates that the octane/water partition coefficient and the partial negative solvent- accessible surface area multiplied by the negative charge are crucial to brain-blood barrier permeability. More- over, we found that the predictions using multiple QSPR models from GA optimization gave quite good results in spite of the diversity of structures, which was better than the predictions using the best single model. The predic- tions for the two external sets with 37 diverse com- pounds using multiple QSPR models indicate that the best linear models with four descriptors are sufficiently effective for predictive use. Considering the ease of computation of the descriptors, the linear models may be used as general utilities to screen the blood-brain barrier partitioning of drugs in a high-throughput fashion.
Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning

Rui Miao,Liang-Yong Xia,Hao-Heng Chen,Hai-Hui Huang,Yong Liang

DOI: https://doi.org/10.1038/s41598-019-44773-4

IF: 4.6

2019-06-19

Scientific Reports

Abstract:Blood-Brain-Barrier (BBB) is a strict permeability barrier for maintaining the Central Nervous System (CNS) homeostasis. One of the most important conditions to judge a CNS drug is to figure out whether it has BBB permeability or not. In the past 20 years, the existing prediction approaches are usually based on the data of the physical characteristics and chemical structure of drugs. However, these methods are usually only applicable to small molecule compounds based on passive diffusion through BBB. To deal this problem, one of the most famous methods is multi-core SVM method, which is based on clinical phenotypes about Drug Side Effects and Drug Indications to predict drug penetration of BBB. This paper proposed a Deep Learning method to predict the Blood-Brain-Barrier permeability based on the clinical phenotypes data. The validation result on three datasets proved that Deep Learning method achieves better performance than the other existing methods. The average accuracy of our method reaches 0.97, AUC reaches 0.98, and the F1 score is 0.92. The results proved that Deep Learning methods can significantly improve the prediction accuracy of drug BBB permeability and it can help researchers to reduce clinical trials and find new CNS drugs.

multidisciplinary sciences
Exploring blood–brain barrier passage using atomic weighted vector and machine learning

Martínez-López, Yoan

DOI: https://doi.org/10.1007/s00894-024-06188-5

IF: 2.172

2024-11-02

Journal of Molecular Modeling

Abstract:This study investigates the potential of leveraging molecular properties, as determined by MD-LOVIs software and machine learning techniques, to predict the ability of compounds to cross the blood–brain barrier (BBB). Accurate prediction of BBB permeation is critical for the development of central nervous system (CNS) drugs. The study applies various machine learning models, including both classification and regression techniques, to predict BBB passage and molecular activity. Notably, classification models such as GBM-AWV (accuracy = 0.801), GLM-CN (accuracy = 0.808), SVMPoly-means (accuracy = 0.980), SVMPoly-AC (accuracy = 0.980), SVMPoly-MI_TI_SI (accuracy = 0.900), SVMPoly-GI (accuracy = 0.900), RF-means (accuracy = 0.870), and GLM-means (accuracy = 0.818) demonstrate high accuracy in predicting BBB passage. In contrast, regression models like ES-RLM-AG ( R 2 = 0.902), IB-IBK ( R 2 = 0.82), IB-Kstar ( R 2 = 0.834), IB-MLP ( R 2 = 0.843), and DRF-AWV ( R 2 = 0.810) exhibit strong performance in predicting molecular activity. The results show that classification models like GBM-AWV, GLM-CN, and SVMPoly variants, as well as regression models like ES-RLM-AG and IB-MLP, achieve high performance, demonstrating the effectiveness of machine learning in predicting BBB permeability.

chemistry, multidisciplinary,biochemistry & molecular biology,biophysics,computer science, interdisciplinary applications
Natural‐Language Processing (NLP) based feature extraction technique in Deep‐Learning model to predict the Blood‐Brain‐Barrier permeability of molecules

Ashok Kumar,Ravi Singh,Powsali Ghosh,Ankit Ganeshpurkar,* Asha,Rayala Swetha,Ravi Bhushan Singh,Dileep Kumar,Sushil Kumar Singh

DOI: https://doi.org/10.1002/minf.202200271

IF: 4.05

2023-07-05

Molecular Informatics

Abstract:Blood‐Brain‐Barrier (BBB) permeability is one of the critical factors in the success and failure of CNS drug development. The most accurate method of measuring BBB permeability involves clinical experiments, which are labour‐intensive and time‐consuming. Thus, numerous efforts were made to use artificial intelligence (AI) to predict molecules' BBB permeability. Most of the previous models are based on calculated descriptors and molecular fingerprints. In the present work, we have developed an NLP‐based feature extraction technique in Deep‐Learning models to predict BBB permeability. We have used the B3DB database and generated SELFIES to extract features from the molecules. We have employed word level and N‐gram tokenization to represent words into numeric vectors. The extracted features were fed into several Artificial Neural Network (ANN) and Bi‐directional Long Short‐Term Memory (LSTM) models. The model, ANN‐10 built using ANN and 6‐gram tokenization, performed best on the independent test set. The accuracy, precision, recall, F1, specificity and AUC of ROC scores were found to be 0.89, 0.91, 0.91, 0.91, 0.85 and 0.90. Thus, the developed model can be used for the early screening of CNS drugs.

chemistry, medicinal,mathematical & computational biology,computer science, interdisciplinary applications
Development of QSAR models to predict blood-brain barrier permeability

Sadegh Faramarzi,Marlene T. Kim,Donna A. Volpe,Kevin P. Cross,Suman Chakravarti,Lidiya Stavitskaya

DOI: https://doi.org/10.3389/fphar.2022.1040838

IF: 5.6

2022-10-20

Frontiers in Pharmacology

Abstract:Assessing drug permeability across the blood-brain barrier (BBB) is important when evaluating the abuse potential of new pharmaceuticals as well as developing novel therapeutics that target central nervous system disorders. One of the gold-standard in vivo methods for determining BBB permeability is rodent log BB; however, like most in vivo methods, it is time-consuming and expensive. In the present study, two statistical-based quantitative structure-activity relationship (QSAR) models were developed to predict BBB permeability of drugs based on their chemical structure. The in vivo BBB permeability data were harvested for 921 compounds from publicly available literature, non-proprietary drug approval packages, and University of Washington’s Drug Interaction Database. The cross-validation performance statistics for the BBB models ranged from 82 to 85% in sensitivity and 80–83% in negative predictivity. Additionally, the performance of newly developed models was assessed using an external validation set comprised of 83 chemicals. Overall, performance of individual models ranged from 70 to 75% in sensitivity, 70–72% in negative predictivity, and 78–86% in coverage. The predictive performance was further improved to 93% in coverage by combining predictions across the two software programs. These new models can be rapidly deployed to predict blood brain barrier permeability of pharmaceutical candidates and reduce the use of experimental animals.

pharmacology & pharmacy
ChemInform Abstract: Mining and Visualizing Large Anticancer Drug Discovery Databases.

Leming M. Shi,Yi Fan,Jae K. Lee,Mark Waltham,Darren T. Andrews,Uwe Scherf,Kenneth D. Paull,John N. Weinstein

DOI: https://doi.org/10.1002/chin.200025256

2000-01-01

ChemInform

Abstract:AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Classification Tree Models for the Prediction of Blood—Brain Barrier Passage of Drugs.

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Prediction of blood‐brain barrier permeability using machine learning approaches based on various molecular representation

Brain Embolism‐Induced Injury of Vascular Endothelial Cells and a Novel Vasoprotective Drug

In Silico Prediction of Blood-Brain Barrier Permeability of Chemical Compounds through Molecular Feature Modeling

ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors [J. Chem. Inf. Comput. Sci. 43, 2137-2152 (2003)]

A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors

Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds

The Barrier and Interface Mechanisms of the Brain Barrier, and Brain Drug Delivery.

Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.

ChemInform Abstract: ADME Evaluation in Drug Discovery. Part 8. the Prediction of Human Intestinal Absorption by a Support Vector Machine.

A merged molecular representation deep learning method for blood-brain barrier permeability prediction

A prediction model for blood–brain barrier permeation and analysis on its parameter biologically

Predicting blood–brain barrier permeability of molecules with a large language model and machine learning

DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy

1. Applications of Genetic Algorithms to the Prediction of Blood-Brain Partitioning of a Large Set of Drugs

Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning

Exploring blood–brain barrier passage using atomic weighted vector and machine learning

Natural‐Language Processing (NLP) based feature extraction technique in Deep‐Learning model to predict the Blood‐Brain‐Barrier permeability of molecules

Development of QSAR models to predict blood-brain barrier permeability

ChemInform Abstract: Mining and Visualizing Large Anticancer Drug Discovery Databases.